• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    FitLife Brands Announces First Quarter 2026 Results

    5/14/26 7:30:00 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $FTLF alert in real time by email

    OMAHA, NE, May 14, 2026 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the first quarter ended March 31, 2026.

    Highlights for the first quarter ended March 31, 2026 include:

    • Total revenue was $25.3 million, an increase of 59% compared to the first quarter of 2025.  
    • Wholesale revenue was $14.1 million, or 56% of total revenue, an increase of 166% compared to the first quarter of 2025.
    • Online revenue was $11.2 million, or 44% of total revenue, an increase of 6% compared to the first quarter of 2025.
    • Gross margin was 37.6% compared to 43.1% during the first quarter of 2025, with the decline in gross margin primarily attributable to the acquisition of Irwin, which historically operated at a lower gross margin than Legacy FitLife.
    • Net income was $1.7 million compared to $2.0 million during the first quarter of 2025, with the decline driven by higher amortization expense and interest expense associated with the acquisition of Irwin.
    • Basic earnings per share and diluted earnings per share were $0.18 and $0.17, respectively, compared to $0.22 and $0.20 during the first quarter of 2025.
    • Adjusted EBITDA was $3.3 million, a 3% decrease compared to the first quarter of 2025.
    • The Company ended the quarter with $37.6 million outstanding on its term loan and $4.2 million outstanding on its revolving line of credit.

    For the first quarter ended March 31, 2026, total revenue was $25.3 million, an increase of 59% compared to $15.9 million during the same period last year.

    Wholesale revenue for the quarter ended March 31, 2026 was $14.1 million, a 166% increase from the same period last year. The Company's recent acquisition of Irwin contributed $10.3 million of wholesale revenue for the quarter ended March 31, 2026, while Legacy FitLife wholesale revenue declined $1.5 million, or 28%, compared to the same period last year.  

    Online revenue for the quarter was $11.2 million, an increase of 6% compared to the quarter ended March 31, 2025. Online revenue accounted for 44% and 67% of the Company's total revenue during the quarters ended March 31, 2026 and 2025, respectively.

    Gross margin for the quarter ended March 31, 2026 was 37.6% compared to 43.1% during the same period in the prior year. The decrease in gross margin is primarily attributable to the acquisition of Irwin, which historically generated a lower gross margin than Legacy FitLife. 

    Net income for the first quarter of 2026 was $1.7 million compared to $2.0 million during the quarter ended March 31, 2025. Basic and diluted earnings per share for the first quarter of 2026 were $0.18 and $0.17, respectively, compared to $0.22 and $0.20 during the first quarter of 2025.  

    Adjusted EBITDA for the quarter ended March 31, 2026 was $3.3 million, a decrease of 3% compared to the same period in 2025.

    As of March 31, 2026, the Company had $37.6 million outstanding on its term loan and $4.2 million outstanding on the revolver, and cash of $1.2 million, or total net debt of approximately $40.6 million, compared to $43.1 million as of December 31, 2025.

    Performance of Brands

    One of the primary metrics used by management to evaluate the performance of the Company's brands is contribution, a non-GAAP financial measure which management defines as gross profit less advertising and marketing expenditures.   Other companies may also report contribution as a performance metric, but their definition or calculation of contribution may differ from the Company's. Management believes that contribution, as defined by the Company, is a particularly relevant performance metric since it incorporates the gross profit associated with a specific brand or collection of brands as well as the advertising and marketing expenditures associated with the same brand or brands. With limited exceptions, other operating expenses incurred by the Company are generally not allocable to a specific brand or collection of brands.

    Legacy FitLife consists of thirteen brands, and Irwin consists of three brands. These collections of brands do not meet the definition of operating segments and are not managed as such.

    Legacy FitLife      
    (Unaudited)      
     2025 2026
     Q1Q2Q3Q4 Q1
           
     Wholesale revenue5,306 5,696 6,686 4,238  3,798 
     Online revenue10,630 10,431 9,978 9,028  8,678 
     Total revenue15,936 16,127 16,664 13,266  12,476 
     Gross profit6,874 6,904 6,542 5,395  5,143 
    Gross margin43.1%42.8%39.3%40.7% 41.2%
    Advertising and marketing1,053 1,191 1,285 1,077  887 
    Contribution5,821 5,713 5,257 4,318  4,256 
    Contribution as % of revenue36.5%35.4%31.5%32.5% 34.1%
           

    For the first quarter of 2026, revenue for Legacy FitLife declined 22% compared to the same period last year due to declines in both online and wholesale revenue. Wholesale revenue decreased 28% as compared to the first quarter of 2025 due to lower sales to certain retail partners, primarily GNC. Online revenue decreased by 18% compared to the first quarter of 2025, primarily driven by lower online sales from MRC.

    Gross margin for Legacy FitLife decreased to 41.2% during the first quarter of 2026 compared to 43.1% during the first quarter of last year. Contribution as a percentage of revenue decreased to 34.1% compared to 36.5% during the first quarter of last year.

    Irwin    
    (Unaudited)    
     2025

     2026

     Q3Q4 Q1
     Wholesale revenue6,510 11,216  10,295 
     Online revenue311 1,428  2,554 
     Total revenue6,821 12,644  12,849 
     Gross profit2,194 3,544  4,374 
    Gross margin32.2%28.0% 34.0%
    Advertising and marketing72 182  358 
    Contribution2,122 3,362  4,016 
    Contribution as % of revenue31.1%26.6% 31.3%
         

    During the first quarter of 2026, Irwin generated 80% of its revenue from the wholesale channel and 20% from online sales. Total revenue for Irwin for the first quarter of 2026 increased 2% sequentially from the fourth quarter of 2025.

    Normalizing for loss of the customers that occurred prior to the acquisition of Irwin by the Company, as well as for the results of Irwin's CBD business, which the Company is in the process of exiting, total revenue for Irwin decreased approximately 13% in the first quarter of 2026 compared to the first quarter of 2025.   Management believes that the year-over-year revenue decline for Irwin is primarily a function of a weak consumer environment, a lack of new product launches, and supply chain challenges including inventory out-of-stock situations.

    Online revenue during the quarter represents transactions through Irwin's websites as well as through Amazon and other e-commerce platforms. The Company began selling Irwin products on Amazon in mid-October, and sales increased rapidly throughout the quarter, with a sequential increase in online revenue of 79% compared to the fourth quarter of 2025. At the end of the first quarter of 2026, Irwin's Amazon sales reached a run-rate of approximately $9.6 million in annual revenue.

    Irwin generated gross margin of 34.0% and contribution as a percentage of revenue of 31.3% during the first quarter of 2026. Excluding amortization of the inventory step-up during the fourth quarter of 2025, Irwin's gross margin and contribution as a percentage of revenue would have been 33.2% and 31.8%, respectively.  

    FitLife Consolidated      
    (Unaudited)      
     2025

     2026

     Q1Q2Q3Q4 Q1
           
     Wholesale revenue5,306 5,696 13,196 15,454  14,093 
     Online revenue10,630 10,431 10,289 10,456  11,232 
     Total revenue15,936 16,127 23,485 25,910  25,325 
     Gross profit6,874 6,904 8,736 8,939  9,517 
    Gross margin43.1%42.8%37.2%34.5% 37.6%
    Advertising and marketing1,053 1,191 1,357 1,259  1,245 
    Contribution5,821 5,713 7,379 7,680  8,272 
    Contribution as % of revenue36.5%35.4%31.4%29.6% 32.7%
           

    For the Company overall, revenue for the first quarter of 2026 increased 59%, gross profit increased 38%, and contribution increased 42% compared to the first quarter of 2025.

    Gross margin decreased to 37.6% compared to 43.1% during the first quarter of last year, with the decline in gross margin primarily attributable to the acquisition of Irwin, which historically operated at a lower gross margin than Legacy FitLife.  

    Contribution as a percentage of revenue decreased to 32.7% compared to 36.5% during the first quarter of last year.  

    Management commentary



    Dayton Judd, the Company's Chairman and Chief Executive Officer, commented, "As previously disclosed, the first quarter of 2026 was a challenging one. The consumer weakness that we initially observed early in the fourth quarter of 2025 accelerated late in the fourth quarter and into the first quarter of 2026. In addition, apparent changes in the Amazon algorithms are causing the Company to alter how it promotes its products.

    "In addition to those exogenous challenges, supply chain difficulties at Irwin also negatively impacted revenue as we dealt with a number of out-of-stock situations for some of our high-velocity products. We estimate that out-of-stock situations resulted in lost revenue of $1.0-1.5 million for Irwin during the first quarter, or more than half of the year-over-year organic decline experienced in the first quarter of 2026.

    "As has been our practice, we continue to allocate our available free cash flow to debt reduction. During the first quarter, we made a scheduled amortization payment of $1.5 million on our term loan in addition to a $1.4 million paydown on our revolving line of credit.

    "While the macro environment and other variables remain challenging, I am encouraged by some signs of improvement in our business. More specifically, monthly revenue increased sequentially throughout the first quarter. In addition, most of our Amazon selling accounts showed sequential improvement over the course of the quarter.   Also, we are pleased to announce the launch of two MusclePharm SKUs in several hundred Kroger stores nationwide beginning in June.

    "Last, we remain excited about the growth of Irwin on Amazon. As previously disclosed, monthly revenue for Irwin on Amazon increased from approximately $0.5 million in December of 2025 to approximately $0.8 million in March of 2026. In the month of April, Irwin revenue on Amazon was approximately $0.9 million. Although the growth rate is slowing due to the higher base of sales, we have experienced further sequential growth in the May month-to-date period. Going forward, we expect continued future growth on Amazon for Irwin as we (1) continue to resolve the out-of-stock situations, (2) successfully set up listings for our remaining products that have not yet been available for sale on Amazon, and (3) launch our portfolio of Canadian products on Amazon Canada later in the second quarter."

    Earnings Conference Call

    The Company will hold an investor conference call on Thursday, May 14, 2026 at 5:00 pm ET. Investors interested in participating in the live call can dial (833) 492-0064 from the U.S. and provide the conference identification code of 133048. International participants can dial (973) 528-0163 and provide the same code.

    About FitLife Brands

    FitLife Brands is a developer and marketer of innovative and proprietary nutritional supplements and wellness products for health-conscious consumers. FitLife markets more than 500 different products online and through various retail locations. FitLife is headquartered in Omaha, Nebraska. For more information, please visit our website at www.fitlifebrands.com.

    Forward-Looking Statements

    Statements in this release that are forward-looking involve known and unknown risks and uncertainties, which may cause the Company's actual results in future periods to be materially different from any future performance that may be suggested in this news release. Such factors may include, but are not limited to, the ability of the Company to continue to grow revenue, and the Company's ability to continue to achieve positive cash flow given the Company's existing and anticipated operating and other costs. Many of these risks and uncertainties are beyond the Company's control. Reference is made to the discussion of risk factors detailed in the Company's filings with the Securities and Exchange Commission including its reports on Form 10-K and 10-Q. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the dates on which they are made.



    FITLIFE BRANDS, INC.

    CONDENSED CONSOLIDATED BALANCE SHEETS

    (in thousands, except per share amounts)

      March 31, 2026  December 31, 2025 
      (Unaudited)     
    ASSETS:        
    CURRENT ASSETS        
    Cash and cash equivalents $1,192  $1,646 
    Accounts receivable, net  7,778   8,765 
    Inventories, net  21,528   21,324 
    Prepaid expense and other current assets  1,142   1,334 
    Total current assets  31,640   33,069 
             
    Property and equipment, net  106   128 
    Right of use asset  581   682 
    Intangibles, net  51,196   51,440 
    Goodwill  19,363   19,393 
    Deferred tax asset  1,222   1,525 
    Derivative asset  72   - 
    Other assets  89   83 
    TOTAL ASSETS $104,269  $106,320 
             
    LIABILITIES AND STOCKHOLDERS' EQUITY:        
    CURRENT LIABILITIES:        
    Accounts payable $6,451  $6,911 
    Accrued expense  5,602   5,429 
    Income taxes payable  1,494   1,704 
    Product returns  830   1,039 
    Term loan – current portion  6,094   6,094 
    Lease liability – current portion  341   433 
    Total current liabilities  20,812   21,610 
             
    Revolving line of credit  4,200   5,600 
    Term loan, net of current portion and unamortized deferred finance costs  31,334   32,849 
    Long-term lease liability, net of current portion  258   272 
    Derivative liability  -   26 
    Deferred tax liability  2,284   2,324 
    TOTAL LIABILITIES  58,888   62,681 
             
    STOCKHOLDERS' EQUITY:        
    Preferred stock, $0.01 par value, 10,000 shares authorized, none outstanding as of March 31, 2026 and December 31, 2025  -   - 
    Common stock, $0.01 par value, 120,000 shares authorized; 9,391 issued and outstanding as of March 31, 2026 and December 31, 2025  94   94 
    Additional paid-in capital  32,230   32,213 
    Retained earnings  13,613   11,893 
    Accumulated other comprehensive loss  (556)  (561)
    TOTAL STOCKHOLDERS' EQUITY  45,381   43,639 
    TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $104,269  $106,320 



    FITLIFE BRANDS, INC. 

    CONDENSED CONSOLIDATED STATEMENTS OF INCOME

    (in thousands, except per share data)

    (Unaudited)

      Three months ended March 31, 
      2026

     2025 
            
    Revenue $25,325 $15,936 
    Cost of goods sold  15,808  9,062 
    Gross profit  9,517  6,874 
            
    OPERATING EXPENSE:       
    Advertising and marketing  1,245  1,053 
    Selling, general and administrative  4,963  2,512 
    Merger and acquisition related  -  332 
    Depreciation and amortization  248  19 
    Total operating expense  6,456  3,916 
    OPERATING INCOME  3,061  2,958 
            
    OTHER EXPENSE       
    Interest expense, net  735  218 
    Foreign exchange (gain) loss  (21) 21 
    Total other expense, net  714  239 
    INCOME BEFORE INCOME TAX PROVISION  2,347  2,719 
            
    PROVISION FOR INCOME TAXES  627  701 
            
    NET INCOME $1,720 $2,018 
            
    NET INCOME PER SHARE       
    Basic $0.18 $0.22 
    Diluted $0.17 $0.20 
    Basic weighted average common shares  9,391  9,213 
    Diluted weighted average common shares  9,991  9,926 



    FITLIFE BRANDS, INC.

    CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (in thousands)

      Three months ended March 31, 
      2026  2025 
             
    CASH FLOWS FROM OPERATING ACTIVITIES:        
    Net income $1,720  $2,018 
    Adjustments to reconcile net income to net cash provided by operating activities:        
    Depreciation and amortization  248   19 
    Allowance for credit losses  58   (3)
    Allowance for inventory obsolescence  (105)  (24)
    Stock-based compensation  17   107 
    Amortization of deferred financing costs  9   11 
             
    Changes in operating assets and liabilities:        
    Accounts receivable  921   (1,062)
    Inventories  16   (1,013)
    Deferred taxes  303   (47)
    Prepaid expense and other assets  94   362 
    Right of use asset  101   27 
    Accounts payable  (452)  1,168 
    Income taxes payable  (185)  318 
    Lease liability  (105)  (20)
    Accrued expense and other liabilities  53   449 
    Product returns  (209)  18 
    Net cash provided by operating activities  2,484   2,328 
             
    CASH FLOWS FROM INVESTING ACTIVITIES:        
    Purchase of property and equipment  -   (24)
    Net cash used in investing activities  -   (24)
             
    CASH FLOWS FROM FINANCING ACTIVITIES:        
    Proceeds from exercise of stock options  -   259 
    Payments on 2025 term loan  (1,524)  - 
    Payments on 2023 term loan  -   (1,125)
    Payments on line of credit  (1,400)  - 
    Net cash used in financing activities  (2,924)  (866)
             
    Foreign currency impact on cash  (14)  36 
             
    CHANGE IN CASH AND CASH EQUIVALENTS  (454)  1,474 
    CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD  1,646   4,520 
    CASH AND CASH EQUIVALENTS, END OF PERIOD $1,192  $5,994 
             
    Supplemental cash flow disclosure        
    Cash paid for income taxes $430  $408 
    Cash paid for interest $742  $238 



    Non-GAAP Financial Measures

    The financial information included in this release and the presentation below contain certain financial measures defined as "non-GAAP financial measures" by the SEC, including non-GAAP EBITDA and non-GAAP adjusted EBITDA. These measures may be different from non-GAAP financial measures used by other companies. The presentation of this financial information, which is not prepared under any comprehensive set of accounting rules or principles, is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. 

      

    As presented below, non-GAAP EBITDA excludes interest, foreign exchange gains and losses, income taxes, and depreciation and amortization. Adjusted non-GAAP EBITDA excludes, in addition to interest, foreign exchange gains and losses, income taxes, depreciation and amortization, stock-based compensation and merger and acquisition related expense and non-recurring gains or losses. The Company believes the non-GAAP measures provide useful information to both management and investors by excluding certain expense and other items that may not be indicative of its core operating results and business outlook. The Company believes that the inclusion of non-GAAP measures in the financial presentation below allows investors to compare the Company's financial results with the Company's historical financial results and is an important measure of the Company's comparative financial performance. 

    The Company's calculation of Adjusted EBITDA for the three months ended March 31, 2026 and 2025 is as follows:



      Three months ended March 31, 
      2026 2025 
      (Unaudited) (Unaudited) 
    Net income $1,720 $2,018 
    Interest expense, net  735  218 
    Foreign exchange (gain) loss  (21) 21 
    Provision for income taxes  627  701 
    Depreciation and amortization  248  19 
    EBITDA  3,309  2,977 
    Non-cash and non-recurring adjustments       
    Stock-based compensation  17  107 
    Merger and acquisition related  -  332 
    Adjusted EBITDA $3,326 $3,416 





    investor@fitlifebrands.com

    Primary Logo

    Get the next $FTLF alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $FTLF

    DatePrice TargetRatingAnalyst
    3/17/2025$21.00Buy
    Lake Street
    9/3/2024$40.00Buy
    ROTH MKM
    More analyst ratings

    $FTLF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by President Hansen Ryan P.

    4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

    5/19/26 4:14:07 PM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 4 filed by Yakatan Seth

    4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

    4/20/26 6:18:18 PM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 5 filed by Yakatan Seth

    5 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

    4/20/26 6:15:00 PM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    $FTLF
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    FitLife Brands Announces First Quarter 2026 Results

    OMAHA, NE, May 14, 2026 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the first quarter ended March 31, 2026. Highlights for the first quarter ended March 31, 2026 include: Total revenue was $25.3 million, an increase of 59% compared to the first quarter of 2025.  Wholesale revenue was $14.1 million, or 56% of total revenue, an increase of 166% compared to the first quarter of 2025.Online revenue was $11.2 million, or 44% of total revenue, an increase of 6% compared to the first quarter of 2025.Gross margin was 37.6% compared

    5/14/26 7:30:00 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    FitLife Brands Announces First Quarter Earnings Call

    OMAHA, NE, May 05, 2026 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife," or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced that it plans to report its financial performance for the first quarter of fiscal 2026 on Thursday, May 14, 2026. In addition, the Company announced that it will hold an investor conference call after market close on May 14, 2026 at 5:00 pm ET.  Investors interested in participating in the live call can dial (833) 492-0064 from the U.S. and provide the conference identification code of 133048.  International participants can dial (973) 528-0163 and provide the same code. About

    5/5/26 3:00:00 PM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    FitLife Brands Announces Fourth Quarter and Full-Year 2025 Results

    OMAHA, NE, April 01, 2026 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the fourth quarter and full year ended December 31, 2025. Highlights for the fourth quarter ended December 31, 2025 include: Total revenue was $25.9 million, an increase of 73% compared to the fourth quarter of 2024.  Wholesale revenue was $15.5 million, or 60% of total revenue, an increase of 213% compared to the fourth quarter of 2024.Online revenue was $10.5 million, or 40% of total revenue, an increase of 4% compared to the fourth quarter of 2024.Excl

    4/1/26 7:00:00 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    $FTLF
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Lake Street initiated coverage on FitLife Brands with a new price target

    Lake Street initiated coverage of FitLife Brands with a rating of Buy and set a new price target of $21.00

    3/17/25 8:22:47 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    ROTH MKM initiated coverage on FitLife Brands with a new price target

    ROTH MKM initiated coverage of FitLife Brands with a rating of Buy and set a new price target of $40.00

    9/3/24 7:48:49 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    $FTLF
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Ordal Todd bought $3,621 worth of shares (300 units at $12.07), increasing direct ownership by 0.48% to 62,488 units (SEC Form 4)

    4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

    4/16/25 8:00:07 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    Director Lingenbrink Matthew bought $36,510 worth of shares (3,000 units at $12.17), increasing direct ownership by 107% to 5,800 units (SEC Form 4)

    4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

    4/16/25 8:00:05 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    Director Lingenbrink Matthew bought $34,089 worth of shares (2,800 units at $12.17) (SEC Form 4)

    4 - FITLIFE BRANDS, INC. (0001374328) (Issuer)

    4/2/25 8:01:06 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    $FTLF
    SEC Filings

    View All

    FitLife Brands Inc. filed SEC Form 8-K: Leadership Update

    8-K - FITLIFE BRANDS, INC. (0001374328) (Filer)

    5/22/26 4:09:22 PM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    FitLife Brands Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - FITLIFE BRANDS, INC. (0001374328) (Filer)

    5/14/26 2:00:30 PM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 10-Q filed by FitLife Brands Inc.

    10-Q - FITLIFE BRANDS, INC. (0001374328) (Filer)

    5/14/26 7:30:55 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    $FTLF
    Leadership Updates

    Live Leadership Updates

    View All

    FitLife Brands Announces Board Transition

    Omaha, NE, April 28, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, announced today the resignation of Todd Ordal as a member of the Company's Board of Directors. Mr. Ordal's resignation, effective on April 25, 2025, was part of the Company's ongoing commitment to refresh board composition on a regular basis in accordance with good corporate governance practices and was not the result of any disagreement with the Company's management or the Board of Directors regarding any matter related to the Company or otherwise. On April 25, 2025, the Board of Directors of

    4/28/25 7:30:00 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    LifeVantage Appoints Dayton Judd to the Board of Directors

    SALT LAKE CITY, Feb. 15, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced the appointment of Dayton Judd to the Company's Board of Directors (the "Board"), effective immediately, in an expansion of the Board. The Company has had discussions with Bradley L. Radoff and Sudbury Capital Fund, LP (collectively with certain of their affiliates, the "Radoff-Sudbury Group"), which owns approximately 12.6% of the Company's outstanding stock, since the Company's fiscal year 2024 annual meeting of shareholders held on November 6, 2023. During these dis

    2/15/24 4:05:00 PM ET
    $FTLF
    $LFVN
    $OPXS
    Medicinal Chemicals and Botanical Products
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Electronic Components

    $FTLF
    Financials

    Live finance-specific insights

    View All

    FitLife Brands Announces First Quarter 2026 Results

    OMAHA, NE, May 14, 2026 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the first quarter ended March 31, 2026. Highlights for the first quarter ended March 31, 2026 include: Total revenue was $25.3 million, an increase of 59% compared to the first quarter of 2025.  Wholesale revenue was $14.1 million, or 56% of total revenue, an increase of 166% compared to the first quarter of 2025.Online revenue was $11.2 million, or 44% of total revenue, an increase of 6% compared to the first quarter of 2025.Gross margin was 37.6% compared

    5/14/26 7:30:00 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    FitLife Brands Announces First Quarter Earnings Call

    OMAHA, NE, May 05, 2026 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife," or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced that it plans to report its financial performance for the first quarter of fiscal 2026 on Thursday, May 14, 2026. In addition, the Company announced that it will hold an investor conference call after market close on May 14, 2026 at 5:00 pm ET.  Investors interested in participating in the live call can dial (833) 492-0064 from the U.S. and provide the conference identification code of 133048.  International participants can dial (973) 528-0163 and provide the same code. About

    5/5/26 3:00:00 PM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care

    FitLife Brands Announces Fourth Quarter and Full-Year 2025 Results

    OMAHA, NE, April 01, 2026 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. ("FitLife" or the "Company") (NASDAQ:FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the fourth quarter and full year ended December 31, 2025. Highlights for the fourth quarter ended December 31, 2025 include: Total revenue was $25.9 million, an increase of 73% compared to the fourth quarter of 2024.  Wholesale revenue was $15.5 million, or 60% of total revenue, an increase of 213% compared to the fourth quarter of 2024.Online revenue was $10.5 million, or 40% of total revenue, an increase of 4% compared to the fourth quarter of 2024.Excl

    4/1/26 7:00:00 AM ET
    $FTLF
    Medicinal Chemicals and Botanical Products
    Health Care